Presentation is loading. Please wait.

Presentation is loading. Please wait.

Ebstein Anomaly Cohort: Update

Similar presentations


Presentation on theme: "Ebstein Anomaly Cohort: Update"— Presentation transcript:

1 Ebstein Anomaly Cohort: Update
Research Team Joseph Dearani Chris Knott-Craig Christian Pizarro Kimberly Holst Jim Meza test

2 EA Cohort Update Status Update Brief Cohort Review Next Steps Timeline for Patient Enrollment Planning ahead, facilitating site initiation

3 Since the last Work Weekend:
Sick Kids’ REB Approval! Research Protocol Data Collection Forms Foundation of Echo CORE Lab

4 Cohort Overview: Research Questions
Classification System Optimal Approach (timing, operation) Neonate Infant Child Early morbidity and mortality Late morbidity, reoperation, mortality Late functional status

5 Cohort Inclusion Criteria: Ebstein anomaly dx at CHSS member institution Neonate to 21 years old Neonate ≤ 1 month Pediatric > 1 month Operative and medically managed patients Exclude: AV-VA discordance HCM, PAPVC, AVSD, genetic syndromes Retrospective (Look Back to 2010) to Prospective

6 Imaging Impacts all aspects of this cohort
Crucial to be accurate and uniform Echocardiogram Core Lab Pre-op TTE, intra-op TEE, post-op TTE 2D and 3D when available Fetal Echocardiograms when available MRI Need standard interpretation

7 1. Classification System
Neonates (GOSE vs other) Fetal? Pediatric patients Correlation of anatomy: Echo MRI Surgery Predictors of valve repairability

8 1. Classification System, cont
To establish prognostic models based on classification system RF for mortality prior to surgery (neonates) Predictors of successful medical management RF for mortality related to surgery Models by age

9 2. Optimal Management Neonates Current practice patterns
Timing of operative intervention Patient anatomy Physiology Operative Approach 1V vs 2V Risk factors Transplant Mortality

10 2. Optimal Management, cont.
Pediatric patients Current practice patterns Timing of operative intervention Physiology, symptoms Patient anatomy Operative Approach 1.5V vs 2V Predictors of valve repairability Optimal anti-arrhythmia procedures

11 3. Early morbidity and mortality
Describe early outcomes Identify operative and perioperative RF Early morbidity Early mortality Determine modifiable risk factors to improve early outcome

12 4. Late morbidity, reop, and mortality
Describe and determine predictors Late arrhythmia Right ventricular dysfunction Exercise intolerance Re-hospitalization Reoperation Risk factors Risk profile and outcomes: Reoperation vs. primary operation Transplant Late survival

13 5. Late functional status
Accurately describe late functional status Exercise tests Quality of life Identify predictors of better/worse function Operative Medication Arrhythmia management

14 Questions regarding Research Protocol and/or Research Questions?

15 Moving Forward: Needed Steps BEFORE enrollment:
Imaging Protocol Refinement of Data Collection Forms Database Construction Training Materials Imaging Study Coordinators Site Initiation Roll-Out Training IRB/REB

16 Imaging Protocol Establishment of Echo CORE group of Echocardiographers Welcome of additional cardiologists Establish Protocols: Image collection Data Collection Forms What images to review Fetal Echocardiograms when available Will require Sick Kids REB amendment

17 Data Collection Forms and Database Construction
Review and make updates if needed Data Center Review Feasible to include in the database Database Construction Research Coordinator Review Feasible to send from individual institutions Changes will be submitted to Sick Kids REB

18 Training Materials and Roll-Out
Imaging Team CORE team Institutional imaging teams Study Coordinators Study Enrollment and Protocol Training Data Collection IRB/REB Submission

19 Updated Timeline October 2016: Initial REB Approval Now: 1-3 months
Establish CORE Lab and needed protocols Refine DCFs if needed Develop Training Materials REB Modifications: 2-3 months to review Database Build: 1 month Institutional Roll-Out: 1-2 months Regulatory process: 2-3 months Patient Enrollment: 6-9 months ..


Download ppt "Ebstein Anomaly Cohort: Update"

Similar presentations


Ads by Google